Production Planning (PP) Dashboard
ECC T-Codes: COOIS / MD01 / COR3Pharmaceutical Batch Manufacturing Records (BMR), cleanroom work center routing, yields, and capacity.
Cleanroom Utilization:88.5% Active Suites
Overall Batch Yield
99.08%+0.4%
Bulk to finished pack>98%
Active Batch Runs
18 Batches+2
Solid, liquid & sterileCap: 22
Schedule Adherence
95.8%+1.2%
Timely stage transitions>94%
Cleanroom HVAC
100% Valid0
Class A/B/C/D suites14 Suites
Solid Oral Capacity
89.2%+3.1%
Tablets & capsulesOptimal
Sterile Fill Line
92.5%+1.0%
Vials & ampoulesNominal
Monthly Throughput
5.2M Units+6.2%
Total volume MTDTarget: 5.0M
Scrap / Reject Rate
0.92%-0.15%
Low formulation loss<1.5%
Monthly Manufacturing Batch Throughput (Planned vs Actual Output)
Comparison across solid oral tablets, hard capsules, and sterile vials
Active Batch Manufacturing Orders (BMRs)
(5 Orders)| Order # | Batch BMR # | Pharmaceutical Product | Dosage Form | Target vs Actual | Batch Yield | Current Stage | Schedule |
|---|---|---|---|---|---|---|---|
| PRD-2026-8812 | BMR-2610-A14 | Paracetamol 500mg Film-Coated Tablet Suite 102 (Class D) | Solid (Tablet) | 498,200 / 500,000 tablets | 99.64% | Coating | On Schedule |
| PRD-2026-8815 | BMR-2610-C09 | Amoxicillin + Clavulanic Acid 625mg Suite 204 (Dehumidified) | Solid (Tablet) | 295,400 / 300,000 tablets | 98.47% | Compression | On Schedule |
| PRD-2026-8819 | BMR-2610-L03 | Salbutamol Sulfate 2mg/5ml Expectorant Syrup Liquid Suite L1 | Liquid Syrup | 44,200 / 45,000 bottles | 98.22% | Blistering | Minor Delay |
| PRD-2026-8822 | BMR-2610-S01 | Sterile Water for Injection 10ml Ampoule Aseptic Filling Suite 5 (Class A/B) | Sterile Injectable | 79,650 / 80,000 ampoules | 99.56% | QA Quarantine | On Schedule |
| PRD-2026-8825 | BMR-2610-M08 | Metformin HCl 500mg Extended Release Suite 105 (Class D) | Solid (Tablet) | 597,100 / 600,000 tablets | 99.52% | Granulation | On Schedule |